These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 850517)

  • 1. Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.
    Kanis JA; Earnshaw M; Heynen G; Ledingham JG; Oliver DO; Russell GG; Woods CG; Franchimont P; Gaspar S
    N Engl J Med; 1977 May; 296(19):1073-9. PubMed ID: 850517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to salmon calcitonin in chronic renal failure: relation to histological and biochemical indices of bone turnover.
    Cundy T; Heynen G; Gaspar S; Earnshaw M; Bartlett M; Paton S; Kanis JA
    Eur J Clin Invest; 1981 Jun; 11(3):177-84. PubMed ID: 6791936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a relationship between plasma immunoreactive calcitonin and bone disease in chronic renal failure.
    Kanis JA; Heynen G; Earnshaw M; Russell RG; Woods CG; Franchimont P; Gaspar S; Oliver D; Ledingham JG
    Adv Exp Med Biol; 1977; 81():571-9. PubMed ID: 899941
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence that endogenous calcitonin protects against renal bone disease.
    Kanis JA; Oliver D; Ledingham JC; Russell RG
    Lancet; 1976 Dec; 2(7999):1322-6. PubMed ID: 63802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
    Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
    Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
    [No Abstract]   [Full Text] [Related]  

  • 7. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of calcitonin on hemodialysis patients with hypercalcemia and renal osteodystrophy.
    Carney SL; Epstein MT
    Uremia Invest; 1984-1985; 8(2):97-101. PubMed ID: 6537690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indexes of bone turnover after bilateral nephrectomy.
    Drüeke T; Touré YI; Zingraff J; Grosnier J
    N Engl J Med; 1978 Aug; 299(5):255. PubMed ID: 661912
    [No Abstract]   [Full Text] [Related]  

  • 10. Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy?
    Ionova D; Zlatarska S; Kirjakov Z
    Nephrol Dial Transplant; 1995; 10(9):1782. PubMed ID: 8559512
    [No Abstract]   [Full Text] [Related]  

  • 11. The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
    Kanis JA; Earnshaw M; Heynen G; Russell RG; Woods CG
    Calcif Tissue Res; 1977 May; 22 Suppl():147-53. PubMed ID: 912516
    [No Abstract]   [Full Text] [Related]  

  • 12. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
    Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
    J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of endogenous and exogenous calcitonin in patients with osteitis fibrosa and chronic renal failure.
    Cundy T; Heynen G; Paton S; Ledingham JG; Russell RG; Oliver DO; Kanis JA
    Proc Eur Dial Transplant Assoc; 1978; 15():524-31. PubMed ID: 740683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.
    Panuccio V; Cutrupi S; Pizzini P; Mallamaci F; Tripepi G; Zoccali C
    Am J Kidney Dis; 2007 Dec; 50(6):1001-8. PubMed ID: 18037100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ultraviolet irradiation on renal osteopathy in patients in the chronic hemodialysis program].
    Koall W; Klette H; Kokot F; Hintner I; Mampel E
    Z Gesamte Inn Med; 1982 Dec; 37(23):805-9. PubMed ID: 7164524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failure.
    Malluche HH; Faugère MC; Ritz E; Caillens G; Wildberger D
    Miner Electrolyte Metab; 1986; 12(2):113-8. PubMed ID: 3960014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
    Nielsen HE; Rømer FK; Melsen F; Christensen MS; Hansen HE
    Clin Nephrol; 1980 Mar; 13(3):103-8. PubMed ID: 7379358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive serum calcitonin and skeletal histology in chronic renal failure.
    Furlong T; Chan YL; Cornish C; McDowall D; Mahony J; Clifton-Bligh P
    Nephron; 1991; 58(2):138-43. PubMed ID: 1865968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P; Hrubý M
    Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.